Wallace Capital Management Inc. Reata Pharmaceuticals Inc Transaction History

Wallace Capital Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$79.22 - $105.37 $1.76 Million - $2.34 Million	22,175 New	22,175 $2.26 Million
Q3 2019 Nov 14, 2019	SELL	$71.26 - $95.75 $516,991 - $694,666	-7,255 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$77.72 - $94.35 $38,860 - $47,175	-500 Reduced 6.45%	7,255 $685,000
Q3 2018 Nov 13, 2018	BUY	$35.64 - $92.06 $178 - $460	5 Added 0.06%	7,755 $634,000
Q2 2018 Aug 13, 2018	BUY	$19.94 - $40.96 $154,535 - $317,440	7,750 New	7,750 $271,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Wallace Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Wallace Capital Management Inc. with notifications on news.